(ASCO) and the American Society for Reproductive Medicine (ASRM) have recommended that the impact of cancer treatments on fertility should be addressed and discussed with all cancer patients of reproductive age prior to cancer treatment, and all patients should be referred to reproductive specialists at the earliest possible opportunity (Ethics Committee of the American Society for Reproductive Medicine, 2005; Loren et al., 2013) . However, little is known about oncologists' knowledge of FP or their attitudes to discussing the matter with patients, especially in less developed countries. A survey of members of the Turkish Society of haematology revealed that 8% of responders had never heard of the concept of FP (Kucuk, Yavasoglu, Bolaman, & Kadikoylu, 2013) . Another recent survey of 103 male oncologists towards sperm cryopreservation in Saudi Arabia showed that 32% of the respondents rarely or never discuss FP with their patients and 39% said they never referred patients to a fertility specialist (Rabah, Wahdan, Merdawy, Abourafe, & Arafa, 2010) .
This survey was carried out to explore the knowledge, attitudes and practice of Iranian oncologists in relation to FP among cancer patients.
| ME THODS

| Participants
This was an analytical cross-sectional study. Oncologists recruited in this survey were Iranian specialists in radiation oncology and haematology who attended four large national and international congresses and symposia, which took place in Iran between October 2015 and February 2016. Inclusion criteria were current practice in an oncology ward and at least one year of working with cancer patients.
| Measures
To measure self-perception of knowledge and attitudes and practice of oncologists regarding FP in cancer patients, a 23-item self-administered questionnaire was developed on the basis of previous research from the United States (US; Forman et al., 2010; Quinn, Vadaparampil, King, et al., 2009) and United Kingdom (UK; Adams, Hill, & Watson, 2013) . A qualitative study of expert opinion regarding FP was undertaken via eight in-depth interviews with experts in gynaecology (two persons), oncology (four persons) and embryology (two persons). Content analysis was undertaken on the qualitative data, and items covering all aspects of FP were extracted and added to the questionnaire. The whole survey was then tailored to the Iranian context and validated by a group of 18 gynaecologists, embryologists, oncologists and methodologists for content, ease of understanding and acceptability. Face validity was undertaken by a Persian literature expert, who investigated whether the developed questionnaire matched the intent of the study, whether the target group understood items in the same way to the researchers, and whether the components of the questionnaire were easily understandable. Also, fonts and graphics were designed by a graphic artist. The final question- Practice behaviours were evaluated using two statements ("I provide written educational content to the cancer patients about FP" and "I give information on fertility centers equipped to provide FP services and refer cancer patients to these centers"). Question response options included yes/no, multiple choice and 4-point Likert scales (greatly, usually, rarely and never) for attitude and practice measurement, and 4-point Likert scales (none, little, intermediate and a lot) for knowledge assessment. The aims of the study were clearly explained to all participants prior to the investigation, and confidentiality and anonymity were assured. Voluntary completion of the questionnaire was considered as consent.
| Statistical analysis
Frequencies were summarised for categorical variables. Continuous variables were expressed as mean ± standard deviation (SD) and 95% confidence intervals (CIs). Knowledge and attitude questions with responses on a 4-point Likert scale were compared using the independent samples t test. The means of these scores show the knowledge or attitude of the population studied. Heeren and D'Agostino, in 1987 , demonstrated that this t test is robust for ordinal scaled data (Heeren & D'Agostino, 1987 
| RE SULTS
A total of 131 oncologists were invited to participate, of whom 103 completed the questionnaire, yielding a response rate of 78.6%. The mean age of the participants was 44.4 (9.6) years and 60 (58.3%)
were men and 43 (41.7%) women. Of the participants, 76 oncologists were married, 47 men (61.8%) and 29 women (38.2%) had a child or children. Characteristics of the oncologists who took part in the survey are detailed in Table 1 . knowledge. The median score on this scale is 2.5. Mean scores for knowledge of GnRH and sperm cryopreservation were 2.77
| Knowledge of FP
(1.098) and 2.64 (1.003), respectively, which are above the median value of 2.5, unlike the scores for knowledge of all the other FP options, which was 2.25 (0.71), well below the median (see Figure 1 ). respectively, and, again, there were no statistically significant differences between male and female oncologists (see Table 2 ). In Table 3 , the oncologists' knowledge of existing centres providing 
| Attitude towards FP
A 4-point Likert scale was used for questions on attitudes towards FP with response options 1 = never, 2 = rarely, 3 = usually and 4 = greatly. The median score on this scale is 2.5. Age was endorsed as the most important reason for discussing FP with patients, mean score 3.75 (0.54), while heredity was considered the least important, mean score of 2.98 (0.87; see Figure 2 Table 4 ).
As seen in 
| Current practice
Referral behaviour was also considered according to the sex of the oncologist and whether or not the oncologist already had a child/children ( 
| D ISCUSS I ON
This study represents the first published survey of Iranian oncolo- views of FP and cancer indicated that the only FP method that the majority of oncologists felt knowledgeable or very knowledgeable about was sperm cryopreservation and the methods most knew least about were testicular cryopreservation and ovarian cryopreservation (Adams et al., 2013) . On the contrary, a nationwide survey conducted among US oncologists revealed that more than 90% of oncologists stated that they were "very knowledgeable"
or "aware of" FP options, specifically embryo, oocyte and ovarian tissue cryopreservation and pretreatment with GnRH agonists (Forman et al., 2010) . Oncologists who are not up to date with current methods or may have difficulty finding specialists for patients interested in preserving fertility (Goodwin et al.., 2007; Wallace, 2007) can be one of several barriers that may limit access to FP for cancer patients. Education and/or training for oncologists about FP options for cancer patients, particularly female patients, may promote discussion of FP (Quinn et al., 2007) .
Findings of the current survey suggest that most oncologists discussed FP with their patients and considered it a priority. Extensive knowledge of fertility is not essential in order to discuss cancer treatment-related infertility with patients, but it is important that oncologists know where to refer the patients (Adams et al., 2013 paediatric oncologists and surgeons, should address the possibility of infertility with patients treated during their reproductive years or with parents or guardians of children and be prepared to discuss FP options and/or to refer all potential patients to appropriate reproductive specialists. The recommendation should be included in the training of oncologists and be part of the informed consent collected before cancer therapy (Loren et al., 2013) . However, perceived barriers are identified for initiating a discussion about FP. The chief barriers to discussion of FP with cancer patients are risk of treatment delay, disease prognosis and the risk of hormonal stimulation on sensitive malignancies (Adams et al., 2013; Louwe et al., 2013; Quinn, Vadaparampil, Bell-Ellison, Gwede, & Albrecht, 2008) . Patient characteristics (e.g., HIV status, homosexuality, gender, aggressiveness of cancer, low likelihood of survival, marital status and number of children) may impact the discussion (Clayton et al., 2008; Rabah et al., 2010; Schover, Brey, Lichtin, Lipshultz, & Jeha, 2002) . In addition, system barriers related to availability and affordability of FP resources must also be addressed (Achille et al., 2006; Quinn et al., 2007) . Other barriers may arise from ethical, social, local, religious and cultural issues that must be considered when discussing FP (Kohler et al., 2011) . Childbearing can be an important goal of family formation and marriage especially in developing countries, where the older generation may depend on their offspring in old age. In Iranian culture, having children is considered very important and infertility may be surrounded by stigma. Therefore, those Iranian patients who survive cancer, especially at a young age, may have strong feelings about childbearing in the future. They also have a great desire to utilise FP services. However, FP is only available to self-funding clients in Iran, and the availability of centres providing FP options across the country is limited. These can TA B L E 5 Importance of fertility preservation and likelihood of discussing fertility preservation with cancer patients stratified by sex of the oncologist and whether or not the oncologist has a child/children all be factors limiting the use of FP in cancer patients who live in the Iranian context. Interestingly, all of these items, whether of a more clinical or personal nature, were strongly endorsed by Iranian oncologists.
In terms of initiation of a discussion and referral, the current survey reports a broadly similar picture to other studies. In another study, most oncologists reported discussing with their patients how their condition and/or treatment may impact on their fertility and felt it important to discuss potential fertility loss as a side effect of cancer treatment and raise awareness of FP options with their patients (Ghorbani et al., 2011) .
Nevertheless, in previous studies, few physicians provided information to patients about preserving fertility (Adams et al., 2013; Forman et al., 2010) . It is worth noting that most of the oncologists who participated in the current survey had a positive attitude towards the importance of , but other studies have reported dissimilar results (Arafa & Rabah, 2011; Forman et al., 2010; Kucuk et al., 2013; Quinn, Vadaparampil, Lee, et al., 2009 ). These differences are not surprising,
given the widely different cultural context in which the surveys took place. It seems that lack of referral to FP networks is a notable barrier to referral behaviours among oncologists.
Loss of fertility is of great concern to many cancer patients of reproductive age who have not started or completed their family at the time of cancer treatment (Yee, Fuller-Thomson, Lau, & Greenblatt, 2012) . Many cancer patients would prefer a biological child to adoption or third-party reproduction (Quinn et al., 2007) . Although most of the patients are interested in FP, they are not routinely informed about the potential fertility risks and available FP options when receiving cancer care (Yee et al., 2012) . According to ASCO and ASRM guidelines, oncologists have a responsibility to inform patients that cancer treatment may affect fertility [12] (Loren et al., 2013) . Failure to do so could be attributable to the existence of gaps in oncologists' knowledge of FP options, as in the present study, or a lack of selfconfidence (Arafa & Rabah, 2011) . Treatment-related infertility in cancer survivors may also lead to significant psychological distress and impaired quality of life, including emotional well-being, sexuality and relationship problems (Carter et al., 2005) . Counselling on FP options may be important in helping patients cope with their current condition (Forman et al., 2010) .
| Limitation
There are several limitations to the current survey. First, selection bias: oncologists with an interest in FP were more likely to respond, so this sample may not be fully representative of all oncologists in Iran. While this may have some impact on the generalisability of results, the response rate was high, 79%, so any impact is likely to be relatively minor. Second, reporting bias: the self-reported nature of the survey may have led to an overestimation of FP behaviour and so may not be representative of actual practice. However, few objective measures of FP knowledge and attitudes among oncologists are available from routine data so this is an unavoidable limitation. education. This in turn should help oncologists to develop appropriate attitudes and practices in relation to FP for cancer patients and prevent loss of fertility. It is also necessary to encourage increased collaboration between oncologists and reproductive specialists.
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